Gold

Carmot Therapeutics, Inc.

Organization Address
409 Illinois St
San Francisco, CA 94158-2509

Organization Phone
4159782159

Website
www.carmot.us

Industry
Bioscience

Organization Description
Carmot Therapeutics applies its proprietary technology, Chemotype Evolution, to address unmet chemical needs in drug discovery, focusing on high-profile targets for which drug leads have been difficult to identify. Founded in 2008 by Drs. Stig K. Hansen and Daniel A. Erlanson, Carmot has built and optimized this powerful platform to rapidly and efficiently unlock therapeutic target space not currently accessible to conventional small molecule technologies. Carmot is currently using Chemotype Evolution to discover novel drug candidates targeting validated pathways in metabolic disease, oncology and inflammation.

Clinical Development Stage
PreClinical